Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA – Get Free Report) saw a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 21,287 shares, a growth of 177.5% from the May 14th total of 7,671 shares. Based on an average daily volume of 7,366 shares, the days-to-cover ratio is presently 2.9 days. Currently, 11.2% of the company’s stock are sold short.
Insider Activity
In other news, Director Lori Anne Kunkel sold 10,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $34.54, for a total transaction of $345,400.00. Following the completion of the transaction, the director directly owned 51,884 shares in the company, valued at approximately $1,792,073.36. This represents a 16.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Helen Louise Collins sold 40,000 shares of the stock in a transaction that occurred on Wednesday, March 25th. The shares were sold at an average price of $35.10, for a total value of $1,404,000.00. Following the transaction, the insider owned 25,000 shares of the company’s stock, valued at approximately $877,500. This trade represents a 61.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 60,000 shares of company stock worth $2,126,550 over the last three months. 37.30% of the stock is currently owned by corporate insiders.
Bitwise MARA Option Income Strategy ETF Trading Up 0.7%
NYSEARCA IMRA traded up $0.11 on Friday, hitting $17.02. 210 shares of the stock traded hands, compared to its average volume of 5,322. The stock has a 50-day moving average of $16.13 and a 200 day moving average of $15.93. Bitwise MARA Option Income Strategy ETF has a twelve month low of $11.99 and a twelve month high of $54.94. The company has a market capitalization of $3.23 million, a P/E ratio of 340.40 and a beta of 2.88.
Bitwise MARA Option Income Strategy ETF Company Profile
IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.
Featured Stories
- Five stocks we like better than Bitwise MARA Option Income Strategy ETF
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Bitwise MARA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bitwise MARA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
